Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2)
Condition(s):Arrhythmias, Cardiac; Heart Diseases; Cardiovascular Diseases; Implantable Cardioverter DefibrillatorLast Updated:May 6, 2013Terminated